No Picture
Trading Ideas

COVID-19 Vaccine Trial Begins, and Inovio Pharmaceuticals Price Target Jumps to $17

“Coronavirus.” For most of this year, most people have been just focused on the one — the novel coronavirus dubbed SARS-CoV-19 that has infected the world with a global pandemic of COVID-19. But did you know there are more than just one kind of coronavirus? Did you know the word itself is more of an adjective than a noun?It’s true. “Coronavirus” in fact describes a whole family of viruses typified by their spiky structure that resembles (to some eyes) a “crown,” or “corona” — and as luck would have it, Inovio Pharmaceuticals (INO) may be developing a knack for treating …read more […]

No Picture
Trading Ideas

Boeing Gets $50 Billion of Orders for Bonds to Boost Crisis Cash

(Bloomberg) — Boeing Co. has already received $50 billion of orders for its bond offering Thursday, as the company comes off of one of its worst quarter on record with the pandemic upending the global aviation industry.The airplane manufacturer is burning through the most cash it ever has with travel at a standstill. Boeing was already hurting from the grounding of the 737 Max before the Covid-19 outbreak, but now it’s looking to shore up liquidity even further by cutting jobs and production.Boeing has already fully drawn on a nearly $14 billion term loan, and Thursday’s bond sale could add …read more […]

No Picture
Trading Ideas

El-Erian: Worst recession since Great Depression ahead, 2009 will look like a flesh wound

Another 3.84 million Americans filed for unemployment benefits last week. The report comes on the heels of worse-than-expected GDP data for the first quarter. Allianz Chief Economic Adviser Mohamed El-Erian joins Yahoo Finance’s On The Move panel to weigh in on why he says there is more pain to come and how the U.S. can avoid the mistakes of the last recession. …read more […]

No Picture
Trading Ideas

Tesla Pares Advance After Einhorn Questions Billings Again

(Bloomberg) — David Einhorn, the president of hedge fund Greenlight Capital, questioned Tesla Inc.’s billing practices again in his latest repartee with the electric-car maker’s chief executive officer, Elon Musk.“I guess the offer of a factory tour was never serious,” Einhorn said in a tweet, referring to an invitation Musk extended last year for the long-time Tesla short seller to visit the company’s plants.Einhorn, who five months ago told Musk he was “beginning to wonder whether your accounts receivable exist,” said Tesla has in the past explained that the balance of money owed by its debtors was elevated by sales …read more […]

No Picture
Trading Ideas

Is Gilead Sciences Stock a Buy Right Now? This Is What You Need to Know

COVID-19 killed the bull market in stocks this year, but at least one stock hasn’t been fazed by the virus. To the contrary, Gilead Sciences (GILD), maker of the Ebola drug-turned-coronavirus drug remdesivir, is enjoying its own private bull market, with its shares up 27% since the year began.On Wednesday, Gilead shared some of its good fortune with the rest of the stock market, too, as a pair of new remdesivir data releases helped spark a rally that sent the S&P 500 up 2.7%.So what did Gilead have to say today?Firstly, according to the company, a National Institute of Allergy …read more […]